Inventor
YE XIANG-YANG
US12 patents
⚠️ This page may combine multiple inventors who share the name “YE XIANG-YANG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
9 patentsUS7279485B2Oct 9, 2007
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO11 citations83
US10968219B2Apr 6, 2021
3-substituted propionic acids as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO2 citations68
US9714231B2Jul 25, 2017
Pyrrolidine GPR40 modulators
BRISTOL MYERS SQUIBB CO4 citations67
US7951793B2May 31, 2011
Substituted heterocyclic derivatives useful as antidiabetic and antiobesity agents and method
BRISTOL MYERS SQUIBB CO2 citations62
US11884661B2Jan 30, 2024
3-substituted propionic acids as αV integrin inhibitors
BRISTOL MYERS SQUIBB CO0 citations58
US11028071B2Jun 8, 2021
Indazole derivatives as alpha v integrin antagonists
BRISTOL MYERS SQUIBB CO0 citations57
US10745384B2Aug 18, 2020
Indazole derivatives as αv integrin antagonists
BRISTOL MYERS SQUIBB CO1 citations57
US7727978B2Jun 1, 2010
Cyclic 11-beta hydroxysteroid dehydrogenase type I inhibitors
BRISTOL MYERS SQUIBB CO1 citations51
US10301260B2May 28, 2019
Pyrrolidine GPR40 modulators
BRISTOL MYERS SQUIBB CO0 citations39
YE XIANG-YANG
3 patentsUS8940716B2Jan 27, 2015
Bicyclic heteroaryl compounds as GPR119 modulators
YE XIANG-YANG6 citations71
US8729084B2May 20, 2014
Benzofuranyl analogues as GPR119 modulators
YE XIANG-YANG2 citations50
US8299054B2Oct 30, 2012
Cyclic 11-beta hydroxysteroid dehydrogenase type 1 inhibitors
YE XIANG-YANG0 citations49